Three-year growth response to growth hormone treatment in very young children born small for gestational age-data

Margaret C S Boguszewski1, Anders Lindberg, Hartmut A Wollmann

  • 1Department of Pediatrics (M.C.S.B.), Federal University of Paraná, Curitiba PR 80060-900, Brazil; Pfizer Inc (A.L.), Endocrine Care, SE-190 91 Sollentuna, Sweden; and Pfizer Inc (H.A.W.), Endocrine Care, 10117 Berlin, Germany.

Insights

Growth hormone (GH) treatment significantly improves height and weight in very young children born small for gestational age (SGA). The existing prediction model for older SGA children accurately estimates growth response in these younger patients.

Area of Science:

  • Pediatric Endocrinology
  • Growth and Development
  • Clinical Research

Background:

  • Children born small for gestational age (SGA) often experience persistent short stature.
  • Early growth failure in SGA children can impact adult height.

Purpose of the Study:

  • To assess the 3-year growth outcomes of growth hormone (GH) therapy in very young SGA children.
  • To validate prediction models for GH treatment response in SGA children aged 2-6 years.

Main Methods:

  • Utilized data from the Pfizer International Growth Database (KIGS).
  • Analyzed growth response in 620 SGA children (birth size <-2 SDS) treated with GH.
  • Compared outcomes in two age groups: 2-4 years (n=156) and 4-6 years (n=464).

Main Results:

  • Both age groups showed significant increases in height and weight standard deviation scores (SDS) after 3 years of GH treatment (P < .01).
  • Median height SDS improved from -3.9 to -2.2 in the younger group and -3.4 to -2.0 in the older group.
  • Median weight SDS also significantly increased in both groups.

Conclusions:

  • GH treatment is effective in improving height and weight in very young SGA children lacking spontaneous catch-up growth.
  • Established prediction models for SGA children accurately estimate growth response in this younger cohort.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
19.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
2.5K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K